课题基金 / 基金详情

Addressing hepatitis C-related discrimination in a post-cure world

Addressing hepatitis C-related discrimination in a post-cure world
解决治愈后世界中与丙型肝炎相关的歧视
批准号:
DP200100941
负责人:
Prof Kate Seear
金额:
$39.35万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2021
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2021-01-01 至 2023-12-31

项目摘要

项目成果

Prof Kate Seear的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project aims to address the legal and policy dimensions of hepatitis C discrimination. Hepatitis C is a major public health challenge linked to profound discrimination, including in law and policy. Treatments introduced in 2016 improved cure rates; optimism about disease elimination is high, but questions remain about discrimination faced by those who are cured. This interdisciplinary project’s goal is to generate new knowledge about hepatitis C discrimination in a post-cure context, and identify opportunities for legal and policy reform. Expected outcomes of the project include better legal, social and policy outcomes for Australians cured of hepatitis C, significantly benefiting these individuals directly and society more broadly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving social, economic and health outcomes through drug policy reforms
  • 批准号:
    FT200100099
  • 项目类别:
    ARC Future Fellowships
  • 资助金额:
    $73.36万
  • 财政年份:
    2021
  • 负责人:
    Prof Kate Seear
  • 依托单位:
Addiction in the Australian legal system: A sociological analysis
  • 批准号:
    DE160100134
  • 项目类别:
    Discovery Early Career Researcher Award
  • 资助金额:
    $22.64万
  • 财政年份:
    2016
  • 负责人:
    Prof Kate Seear
  • 依托单位:
国内基金
海外基金
新生期接种乙肝疫苗(hepatitis B vaccine,HBV)影响小鼠情绪相关行为及其机制研究
  • 批准号:
    31600836
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    杨俊华
  • 依托单位:
基于反式互补的新型丙型肝炎病毒细胞感染模型的建立及其在丙肝研究中的应用
T细胞识别的鳞状细胞癌1型抗原增强干扰素-α抗丙型肝炎病毒作用的研究
  • 批准号:
    81170386
  • 项目类别:
    面上项目
  • 资助金额:
    45.0万元
  • 批准年份:
    2011
  • 负责人:
    赵鸿
  • 依托单位:
慢性乙肝新型可复制型DNA疫苗的免疫增效策略研究